Curaleaf Holdings (CURLF) Other Non-Current Liabilities (2019 - 2025)

Curaleaf Holdings (CURLF) recorded quarterly Other Non-Current Liabilities of $531.5 million in Q4 2025, up 8546.62% quarter-over-quarter from $6.1 million in Q4 2024, and up 8546.62% on a YoY basis from $6.1 million in Q4 2024.

Curaleaf Holdings (CURLF) Other Non-Current Liabilities (2019 - 2025) Analysis & Trends

Curaleaf Holdings' Other Non-Current Liabilities history runs 7 years deep, the most recent figure standing at $531.5 million for Q4 2025.

  • In Q4 2025, Other Non-Current Liabilities rose 8546.62% year-over-year to $531.5 million; the TTM figure through Dec 2025 stood at $531.5 million (up 8546.62% YoY), while the FY2025 annual figure was $531.5 million, up 8546.62% from the prior year.
  • Other Non-Current Liabilities was $531.5 million for Q4 2025 at Curaleaf Holdings, up from $6.1 million in the prior quarter.
  • In the past five years, Other Non-Current Liabilities ranged from a high of $6.6 billion in Q1 2022 to a low of $3.8 million in Q3 2022.
  • Historically, Other Non-Current Liabilities has averaged $531.5 million across 5 years, with a median of $7.0 million in 2023.
  • The sharpest annual moves came in 2022 and 2023: Other Non-Current Liabilities jumped 170914.49% in 2022, then sank 83.77% in 2023.
  • A 5-year view of Other Non-Current Liabilities shows it stood at $38.0 million in 2021, then decreased by 23.38% to $29.1 million in 2022, then tumbled by 83.77% to $4.7 million in 2023, then surged by 30.12% to $6.1 million in 2024, then jumped by 8546.62% to $531.5 million in 2025.
  • The last three Other Non-Current Liabilities figures came in at $531.5 million (Q4 2025), $6.1 million (Q4 2024), and $378.2 million (Q3 2024), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Teva Pharmaceutical Industries 38.34 Bn 34.60 Bn 1.97 Bn
2 Zoetis 33.27 Bn 31.33 Bn 1.62 Bn
3 United Therapeutics 23.75 Bn 21.60 Bn 648.10 Mn
4 Aurora Cannabis 17.11 Bn 17.03 Bn 33.43 Mn
5 Neurocrine Biosciences 16.37 Bn 15.05 Bn 800.70 Mn
6 Elanco Animal Health 11.78 Bn 11.35 Bn 785.00 Mn
7 Alkermes 7.05 Bn 6.54 Bn -116.06 Mn
8 Lantheus Holdings 6.49 Bn 5.99 Bn 230.92 Mn
9 Hims & Hers Health 6.19 Bn 5.44 Bn 396.79 Mn
10 Curaleaf Holdings - - 157.29 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 531.51 Mn
Dec 31, 2024 6.15 Mn
Sep 30, 2024 378.19 Mn
Jun 30, 2024 339.82 Mn
Dec 31, 2023 4.72 Mn
Sep 30, 2023 4.75 Mn
Jun 30, 2023 7.01 Mn
Dec 31, 2022 29.11 Mn
Sep 30, 2022 3.80 Mn
Jun 30, 2022 9.38 Mn
Mar 31, 2022 6.61 Bn
Dec 31, 2021 37.99 Mn
Sep 30, 2021 3.86 Mn
Jun 30, 2021 4.10 Mn
Mar 31, 2021 3.86 Mn
Dec 31, 2020 1.90 Mn
Sep 30, 2020 246,000.00
Dec 31, 2019 32.62 Mn